Orthocell Ltd (AU:OCC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Limited (ASX: OCC) has requested an immediate trading halt as they prepare to announce a new regulatory approval for their product, Remplir. The halt will remain in effect until either the announcement is made or trading resumes on Wednesday, 9 October 2024. This strategic pause aims to manage market orderliness and fairness in anticipation of the forthcoming news.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.